Colonic pneumatosis and intestinal perforations with sunitinib treatment for renal cell carcinoma.
Flaig
Thomas W
TW
Department of Medicine, Division of Medical Oncology, University of Colorado Denver School of Medicine, Mail Stop 8117, P.O. Box 6511, Aurora, CO, USA. Thomas.Flaig@UCHSC.edu
Kim
Fernando J
FJ
La Rosa
Francisco G
FG
Breaker
Kathryn
K
Schoen
Jonathan
J
Russ
Paul D
PD
D000970:Antineoplastic Agents / Q000009:adverse effects*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007211:Indoles / Q000009:adverse effects*; D007416:Intestinal Perforation / Q000139:chemically induced* / Q000000981:diagnostic imaging; D007680:Kidney Neoplasms / Q000188:drug therapy*; D011006:Pneumatosis Cystoides Intestinalis / Q000139:chemically induced* / Q000473:pathology; D011758:Pyrroles / Q000009:adverse effects*; D011859:Radiography; D000077210:Sunitinib
D000970:Antineoplastic Agents; D007211:Indoles; D011758:Pyrroles; D000077210:Sunitinib